Publications by authors named "Rodolphe Garraffo"

Claim this Profile
T
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, François Parant, Nicolas Venisse, Rodolphe Garraffo

Br J Clin Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A HPLC-DAD method to facilitate large-scale therapeutic drug monitoring of dalbavancin.
Alexandre Destere, Diane Merino, Laurent Bonesso, Thibaud Lavrut, Anaïs Bernasconni, Rodolphe Garraffo

J Chromatogr B Analyt Technol Biomed Life Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Sihem Benaboud, Caroline Solas, Stephane Bouchet, Matthieu Gregoire, Florian Lemaitre, Rodolphe Garraffo

J Antimicrob Chemother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.
Gaurav Kumar, Jacqueline Cottalorda-Dufayard, Rodolphe Garraffo, Francine De Salvador-Guillouët, Eric Cua

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.
Axel Ursenbach, Vincent Max, Marine Maurel, Firouzé Bani-Sadr, Amandine Gagneux-Brunon, Rodolphe Garraffo

J Antimicrob Chemother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Nicolas Venisse, Gilles Peytavin, Stephane Bouchet, Marie-Claude Gagnieu, Rodolphe Garraffo

Antiviral Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study).
Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, Aude Tavenard, Sylvie Quaranta

Antivir Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Elisa Demonchy, Johan Courjon, Estelle Ughetto, Matthieu Durand, Karine Risso, Rodolphe Garraffo

Int J Antimicrob Agents· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
Pierre Gantner, Firouze Bani-Sadr, Rodolphe Garraffo, Pierre-Marie Roger, Michèle Treger

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.
Paul de Boissieu, Moustapha Dramé, François Raffi, André Cabie, Isabelle Poizot-Martin, Rodolphe Garraffo

Medicine (Baltimore)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
Farid Kheloufi, Eric Bellissant, Laurent Cotte, Isabelle Poizot-Martin, Sylvie Quaranta, Rodolphe Garraffo

AIDS· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.
Isabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, Philippe Colson, Lionel Piroth

HIV Clin Trials· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.
Lucia Taramasso, Chiara Dentone, Anna Alessandrini, Bianca Bruzzone, Giancarlo Icardi, Rodolphe Garraffo

Int J STD AIDS· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Minh Patrick Lê, Caroline Solas, Rodolphe Garraffo, Marie-Claude Gagnieu, Patrice Muret

J Antimicrob Chemother· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?
Caroline Solas, Elodie Pambrun, Maria Winnock, Dominique Salmon, Isabelle Poizot-Martin, Rodolphe Garraffo

AIDS· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils.
Rodolphe Garraffo, Thibaud Lavrut, Jacques Durant, Laurence Héripret, Marie-Ange Sérini

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
Dominique Hubert, Evelyne Le Roux, Thibaud Lavrut, Benoit Wallaert, Philippe Scheid, Rodolphe Garraffo

Antimicrob Agents Chemother· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults.
Fidéline Collin, Geneviève Chêne, Sylvie Retout, Gilles Peytavin, Dominique Salmon, Rodolphe Garraffo

Ther Drug Monit· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.
Camille Roucairol, Stéphane Azoulay, Marie-Claire Nevers, Christophe Créminon, Thibault Lavrut, Rodolphe Garraffo

Antimicrob Agents Chemother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.
Matthieu Prot, Laurence Heripret, Nathalie Cardot-Leccia, Christophe Perrin, Myriam Aouadi, Rodolphe Garraffo

Antimicrob Agents Chemother· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lopinavir/ritonavir combination and total/HDL cholesterol ratio.
Laure Valerio, Eric Fontas, Christian Pradier, Thibaud Lavrut, Rodolphe Garraffo

J Infect· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patients.
Stéphane Azoulay, Marie-Claire Nevers, Christophe Créminon, Laurence Heripret, Rodolphe Garraffo

J Immunol Methods· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results.
Philippe Clevenbergh, Rodolphe Garraffo, Jacques Durant, Pierre Dellamonica

AIDS· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study.
Valérie Olivier, Jean-Philippe Lacour, Aline Mousnier, Rodolphe Garraffo, Roger A Monteil

Arch Dermatol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluconazole therapy for Candida albicans urinary tract infections in infants.
Valérie Triolo, Martine Gari-Toussaint, Florence Casagrande, Rodolphe Garraffo, Christian Dageville

Pediatr Nephrol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis